Invention Grant
- Patent Title: Stat3 pathway inhibitors and cancer stem cell inhibitors
-
Application No.: US14499299Application Date: 2014-09-29
-
Publication No.: US09834532B2Publication Date: 2017-12-05
- Inventor: Zhiwei Jiang , Chiang Jia Li , Wei Li , David Leggett
- Applicant: BOSTON BIOMEDICAL, INC.
- Applicant Address: US MA Cambridge
- Assignee: BOSTON BIOMEDICAL, INC.
- Current Assignee: BOSTON BIOMEDICAL, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Boston Biomedical, Inc
- Agent Yi Liu, Esq.; Christopher D. Southgate, Esq.
- Main IPC: C07D307/92
- IPC: C07D307/92 ; C07D333/74 ; A61K31/38
Abstract:
The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrent Stat3 pathway activity; to pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20150018410A1 NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS Public/Granted day:2015-01-15
Information query
